"My experience with Dr. Abdalla and
the Surgical Oncology team has been absolute perfection. Extremely
professional, knowledgeable, compassionate, and confident. I thoroughly
believe in my team of doctors and the plan. They are 'winners', and they
have helped me be a 'winner' as well."
Dr. Ahmed Abdalla serves as a medical oncologist and an assistant professor of interdisciplinary clinical oncology at the USA Health Mitchell Cancer Institute. He received his medical degree from the University of Khartoum College of Medicine in Khartoum, Sudan. He completed a residency in internal medicine at Hurley Medical Center/Michigan State University in Flint, Mich., and a fellowship at Ascension St. John Hospital, Van Elslander Cancer Center in Grosse Pointe, Mich. He also did six months training in investigational drug development at the University of Texas Health Science Center at San Antonio.
Abdalla is a fellow of the American College of Physicians and a member of the American Society of Clinical Oncology, the American Society of Medical Oncology, the Alpha Omega Alpha Honor Society and the Sudanese American Medical Association. Abdalla’s research has been published in numerous publications.
“The first step of colon cancer prevention is through regularly scheduled screenings,” said Ahmed Abdalla, M.D., medical oncologist at MCI.
In 2022, USA Health became the only health system in Alabama and the upper Gulf Coast region to achieve accreditation from the National Accreditation Program for Rectal Cancer.
USA Health employees recognized in the Class of 2023 include Ahmed Abdalla, M.D.; Phillip Henderson, D.O.; Antwan J. Hogue, M.D.; Kristen Roberts, CPA; and Melody Zeidan, J.D., M.D.
Ahmed Abdalla, M.D., brings a special interest in gastrointestinal malignancies and phase 1 clinical trials to the Mitchell Cancer Institute.
